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Abstract 
Mask Projection Microstereolithography (MPμSL) selectively cures entire layers of 
photopolymer to create three-dimensional parts with features on the micron scale.  The resolution 
and scale of MPμSL are ideal for fabricating tissue engineering scaffolds with designed 
mesostructure.  While MPμSL have excellent resolution, there are few biocompatible materials 
that are compatible with the vat photopolymerization processes.  A novel diacrylate 
functionalized Pluronic L-31 block-copolymer and poly(propylene glycol diacrylate) were 
synthesized and processed with MPμSL.  The resulting structures were analyzed for 
biocompatibility, as well as accuracy and mechanical strength to assess feasibility for use in 
tissue engineering scaffold fabrication. Preliminary fabricated scaffold geometries are presented 
to validate experimental results. 
 
1.  Introduction 
 
1.1. The Need for Tissue Engineering Scaffolds 
The goal of Regenerative Medicine is to repair or replace damaged or diseased tissues to 
reestablish normal functionality.  Tissue Engineering uses cells, materials, and physical or 
chemical stimuli to create Tissue Engineering constructs that can be used as tissue replacements 
[1, 2].  Often, stem cells are chosen because they have the ability to differentiate into multiple 
cell types.  By differentiating these stem cells into a variety of cell types, the Tissue Engineering 
construct possesses greater functionality than those engineered with a single differentiated cell 
type [2].   
 
The role of a Tissue Engineering scaffold is to provide cells with both mechanical support 
and an environment that has enough porosity to allow for diffusion of essential nutrients [3, 4].  
Performance of a tissue engineering scaffold has been shown to be dependent on the structure, 
specifically the porosity and pore size, of the matrix. Highly porous support structures are 
favorable for mass transport, delivering cell mass for tissue regeneration [5]. Furthermore, high 
porosity is desirable for diffusion of nutrients and waste products to and from the tissue growth, 
as well as for vascularization, which are requirements for successful cell growth. While a large 
surface area favors cell attachment, the surface area/volume ratio of a porous material is 
dependent on density and diameter of pores. Furthermore, the diameter of the cells dictates the 
minimum pore size. When defining porosity and pore size, considerations must be made such 
that scaffolds retain good mechanical properties while also being permeable and porous for the 
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transport of cells and nutrients [5, 6]. Managing the tradeoff between porosity and mechanical 
strength poses a significant challenge for the field of Tissue Engineering. 
 
Incorporating vascularization into Tissue Engineering scaffolds has often been cited as the 
most significant barrier in the field [7].  Insufficient vascularization, the lack of vessels that 
allow for nutrient diffusion and mass transport to cells, leads to apoptosis.  Artificial skin 
constructs, which have shown success in clinical settings, have little need for built-in 
vascularization because they are thin enough to allow for adequate diffusion through them [8].  
However, a vascular network is essential for tissues thicker than a few hundred microns.  A 
majority of the organs which are in scarce supply for transplant, such as the kidney, liver, 
pancreas, and heart, are thick solid tissues.  To reconstruct these complex tissues, it is necessary 
to create Tissue Engineering scaffolds with adequate vascularization.   
 
1.2. Additive Manufacturing of Tissue Engineering Scaffolds 
Conventional fabrication techniques including particulate leeching, gas foaming, and 
electrospinning have often been used to create tissue engineering scaffolds [1, 9].  Unfortunately, 
these techniques have a number of shortcomings that make them less than idea for tissue 
engineering scaffold fabrication.  Most notably, these techniques do not control the precise 
placement of material in the scaffold.  While particulate leeching is able to control pore size and 
electrospinning produces fibers of a known diameter, these techniques cannot control tortuosity 
and pore size, placement and distribution all at the same time [10].  The resulting scaffolds are 
not optimized for cell growth and mechanical strength.  Figure 1 (left) shows a poorly optimized 
scaffold made by gas foaming that has high surface area and porosity, but low mechanical 
strength and pore interconnectivity [11].  This lack of pore interconnectivity results in a poorly 
vascularized scaffold that cells will have trouble permeating through.  Figure 1 (right) shows a 
scaffold that has small feature sizes and good pore interconnectivity but a random distribution of 
pores throughout the scaffold [12]. 
 
      
Figure 1: A scaffold fabricated via gas foaming (left) [11] and one made via electrospinning 
(right) [12] 
 
Additive Manufacturing (AM) technologies allow for the selective placement of material and 
allow for the fabrication of scaffolds with designed geometries that can be optimized for Tissue 
Engineering.  These techniques use an additive, layer-by-layer manufacturing process, where the 
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geometry of each layer can be designed and controlled. Stacking these layers in a consecutive 
fashion enables the design of complex 3D parts. The advantage of AM in Tissue Engineering is 
the ability to control both microstructure, which enables the creation of vascularization, as well 
as macrostructure. Several AM processes have been considered for scaffold fabrication, 
including selective laser sintering, extrusion, binder jetting, and Stereolithography [4, 13-15].   
 
It is important to be able to fabricate scaffolds with feature that are comparable in size to the 
cells that will be seeded onto them (on the order of 10 μm) [16].  Scaffolds with feature sizes that 
do not extend down into this range will not allow for as much surface area onto which cells can 
attach nor would they provide the extensive vascularization that is essential for an optimized 
tissue engineering scaffold.  Fused Deposition Modeling (FDM) is often considered as a 
candidate for creating scaffolds because it can create relatively large objects rapidly [15].  It is 
also an inexpensive process and it is simple to lay down filament in offset patterns to make 
scaffold like structures.  However, as can be seen in Figure 2, the smallest pore sizes that can be 
achieved with FDM  processes are often 500 μm or greater in diameter and the geometries are 
typically limited to “log-cabin” lay-ups of overlapping extrudate roads that feature periodic cell 
morphologies [14].  Scaffolds made via binder jetting and selective laser sintering present similar 
drawbacks due to the relatively large powder particles [17-19].  Systems that extrude cells 
directly onto the build platform have become quite popular recently.  These systems, such as the 
3D Bioplotter produced by EnvisionTEC and custom machines of similar design have the ability 
to place differentiated cells precisely where they are desired [20, 21].  However, the tissue 
engineering constructs that these systems fabricate are hydrogels or other materials which have 
little mechanical strength.  In addition, cells need to be kept viable during the printing processes.  
The cells are generally extruded in relatively 
large numbers instead of one by one, which 
lessens the control that one has over the 
placement of material in the construct.  Given 
the goal of fabricating designed scaffolds 
with vascularization pathways on the micron 
scale, the authors chose 
Microstereolithography as a manufacturing 
platform due to its excellent resolution 
despite the disadvantage that it does not 
directly incorporate cells into the fabrication 
process. 
 
Figure 2: A scaffold fabricated via FDM[14] 
 
1.3. Mask Projection Microstereolithography (MPμSL) 
Mask Projection Microstereolithography is a relatively new Additive Manufacturing 
technique capable of fabricating complex three-dimensional structures with micron-sized 
features [18].  When a photopolymer is exposed to light of sufficient energy and intensity, a 
crosslinking process is initiated that results in the solidification of a polymeric network.  
Microstereolithography systems use a dynamic mask to pattern light as opposed to a scanning 
laser used in Stereolithography systems.  Mask Projection systems use digital light processing 
(DLP) technology to create a dynamic mask that can be projected onto the surface of the 
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prepolymer all at once.  Ultraviolet light is created by a lamp, LED, or laser and is conditioned 
with a series of optics that can include collimating lenses, wavelength filters, and homogenizing 
rods.  The light is projected onto a digital micromirror device (DMD) that is made up of 
hundreds of small mirrors that pattern the light and selectively project it onto the surface of the 
prepolymer.  A number of research groups have created Microstereolithography systems and 
used them to create tissue engineering scaffolds [4, 16, 22-27]. 
 
1.4. Biocompatible Photopolymers 
Unfortunately, the majority of photopolymers do not exhibit strong biocompatibility[4].  Poly 
(propylene fumarate) (PPF) is the most widely used biocompatible and bioresorbable 
photopolymer in Stereolithography with tissue engineering scaffold applications [23, 27-32].  
Several researchers have used other biocompatible polymers in an attempt to create tissue 
engineering scaffolds with a wider range of properties [4, 33].  However, the number and 
diversity of photopolymers that have been shown to be biocompatible is quite small.  To further 
the use of this high-resolution AM process for fabricating tissue engineering scaffolds, it is 
crucial to identify and develop novel biocompatible photopolymers with a variety of mechanical 
and chemical properties that can be used in tissue engineering scaffolds.   
 
To address this gap in the research, two photopolymers were investigated: Pluronic L-31 
diacrylate and poly(propylene glycol diacrylate) (PPGDA).  Pluronic L-31 is a novel block 
copolymer not before used in MPμSL that contains blocks of poly(ethylene glycol) (PEG) and 
poly(propylene glycol) (PPG), and was chosen as this family of materials has been reported to be 
biocompatible [34].  In addition, Pluronic L-31 is a commercially available diol available in a 
range of molecular weights that undergoes a facile functionalization reaction allowing it to be 
UV cureable telechelic diacrylate.  The pluronic family of materials consists of block copolymers 
made up of PPG and PEG blocks of various lengths and arrangement.  These block copolymers 
have higher order structures than polymers made up of just a single monomer.  In addition, 
differences in solubility of the PPG and PEG blocks may impart additional nanoscale structure 
for optimizing cell adhesion.  Applying Pluronics with variable block segment lengths and 
arrangements will provide control over the nanoscale morphology of the material.   
 
Although readily available and considered to have acceptable biocompatibility, PPGDA has 
not been processed via MPμSL.  The effects of the poly(ethylene glycol) endgroups on the 
Pluronic L-31 will be investigated by comparing the results obtained from PPGDA and Pluronic 
L-31. 
 
In Section 2, the MPμSL processs – both the apparatus and the process model – is explained.  
Section 3, describes the materials and experimental methods used to answer following specific 
research questions: 
- What are the process parameters that will allow for PPGDA and Pluronic L-31 to be 
fabricated? 
- What are the minimum feature sizes and accuracies that the MPμSL system can achieve 
with these materials? 
- What are the mechanical properties of these materials and how do they compare to actual 
tissue? 
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- Do PPGDA and Pluronic L-31 have adequate biocompatibility to be used as materials in 
tissue engineering scaffolds? 
Section 4, presents and discusses the results obtained from implementing these methods.  Finally, 
in Section 5, general conclusions and future research opportunities are explored.  
 
 
2. Mask Projection Microstereolithography 
 
2.1. MPμSL Machine 
The MPμSL machine shown in Figure 3 was developed at Virginia Tech and consists of a 
UV light source, conditioning optics, a mirror, a dynamic mask connected to a computer, 
imaging optics, and a prepolymer container with a stage mounted on a linear actuator [35].  A 
LightningCure LC-L1V3 UV LED system by Hamamatsu was chosen as a source of ultraviolet 
light.  The conditioning optics (Edmund Optics) ensure that the entire dynamic mask is 
illuminated by UV light while the imaging optics focus the patterned light onto the prepolymer 
surface and reduce the image dimensions by a factor of two.  The dynamic mask, a FlexLight X1 
DLP Development System (Keynote Photonics) consists of a DLP 0.95 1080p DMD from Texas 
Instruments and a developer board.  The DMD is a 1920 x 1080 array of aluminum micromirrors 
that measures 0.95-inch along the diagonal.  Each square micromirror has a side length of 10.8 
μm.  The imaging optics reduce the image dimensions by a factor of 2 so the effective projection 
area of each micromirror on the surface of the photopolymer surface is 5.4 μm x 5.4 μm.  Due to 
the optics of the system, the maximum part size in the XY plane is 6mm by 8mm.  The Z 
direction is currently limited to 36mm.  A linear actuator (Zaber NA11B60) was used to control 




Figure 3: Schematic of the Mask Projecting Microstereolithography machine 
 
2.2 Fabrication Process 
Like most Additive Manufacturing processes, Microstereolithography fabricates parts from a 
computer aided design (CAD) file [18].  The Microstereolithography Fabrication process begins 
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first by slicing a three-dimensional CAD model into individual images that can be projected onto 
the prepolymer surface.  One can use an Additive Manufacturing software environment, such as 
NetFabb to create slices (saved as bitmap images) of a desired thickness (25 μm was used).   
 
A LabView program was used to control the projection of these images by the DMD and the 
movement of the stage.  The prepolymer container was filled and the stage lowered until it was 
just submerged.  The LabView program then turned individual mirrors “on” or “off” to represent 
the first image.  The UV light passed from the LED lamp through the conditioning optics and 
mirror to the DMD.  This resulted in the image being projected from the DMD onto the thin 
layer of prepolymer directly above the stage.  The image was projected for a certain amount of 
time based upon the working curve of the material being used (generally between one and five 
seconds).  After this set time, the DMD mirrors are turned “off” so that no light is projected into 
the prepolymer container and the stage is lowered into the container.  The stage was completely 
submerged and then returned to one layer thickness below the surface.  The LabView software 
loads the next layer’s image and the process was repeated until the part was completely 
fabricated. 
 
After the part has been fabricated, the stage was removed and the part separated from the 
stage with a blade.  The part was washed with a few drops of isopropyl alcohol (IPA) to remove 
any uncured prepolymer.  The part can then be post-cured by placing it in the path of the UV 
lamp.  This helps to ensure that the polymer was fully crosslinked. 
 
2.3 The Working Curve 
To successfully process photopolymers via Stereolithography, one must first determine its 
two characteristic material properties: critical exposure (Ec) and depth of penetration (Dp).  The 
Working Curve, first presented by Jacobs in 1992 provides a means of determining these two 
parameters [18, 36].  The expression is based on the Beer-Lambert law of absorption and is 
defined as:  
𝑪𝒅 = 𝑫𝒑 𝐥𝐧(𝑬 𝑬𝑪⁄ ) 
 The Working Curve relates the exposure of light provided at the prepolymer surface (E) and the 
depth to which the prepolymer is crosslinked into a polymer (cure depth, Cd).  The minimum 
exposure required to begin polymer crosslinking is the critical exposure (Ec). 
 
It is essential to determine the Working Curve of a polymer that is to be fabricated so that the 
prepolymer surface can be exposed to the necessary amount of UV energy for polymer curing.  
To determine the working curve, one provides a series of varied exposures to the resin surface 
and measures the thickness of the resulting thin film. The thickness at each exposure is plotted 
on a semi-log plot; the working curve typically shows a linear relationship between the cure 
depth and the natural log of exposure.  The critical exposure is located at the resultant curve’s x-
intercept and depth of penetration is determined by analyzing the slope of the curve. Additional 
details are provided in Section 3.2.1. 
 
 
3. Materials and Methods 
To fabricate PPGDA and Pluronic L-31 via Microstereolithography and characterize these 
polymers, a variety experimental methods and materials were utilized.  The methods were used 
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to determine the processing parameters and mechanical properties of the polymers, their 




PPGDA, a polyfunctional acrylic monomer, was acquired from Sigma Aldrich (CAS 52496-
08-9).  Pluronic L-31 was acquired from Sigma Aldrich (CAS 9003-11-6).  Biological materials 
including Dulbecco’s phosphate buffered saline (DPBS), media (10% fetal bovine serum and 1% 
Pen/Strep to media composition), trypsin, trypan blue, fibronectin, and calcein AM and eithidium 
homodimer dyes were purchased from Invitrogen (Carlsbad, CA). The MC3T3-E1 cell culture 
was obtained from the American Type Culture Collection (ATCC).  The CellTiter 96 AQueous 
One Solution Cell Proliferation MTS Assay (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) was obtained from Promega 
(Madison, WI). 
 
3.1.1 Poly (Propylene Glycol) Diacrylate 
The PPGDA had an average molecular weight (Mn) of 800, and contains 100 ppm of both 
BHT (butylated hydroxytoluene) and MEHQ (mono methyl ether of hydroquinone) which act as 
photoinhibitors and prevent the polymerization of the PPGDA during normal handling.  PPGDA 
contains reactive diacrylate end groups and thus required no functionalization to allow for UV 
curing. 
 
3.1.2 Pluronic L-31 Functionalization 
Pluronic L-31 is a difunctional block copolymer with chemical formula poly(ethylene 
glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol).  The Pluronic L-31 used in 
this study consisted of a central block of 17 PPG monomers terminated on either end by one 
PEG monomer.  The Pluronic L-31 exhibits both hydrophilic (derived from the PEG monomers) 
and hydrophobic properties (derived from the PPG monomers).  The Pluronic L-31 prepolymer 
was functionalized with reactive diacrylate end groups, making it compatible with the photo-
crosslinking process. The functionalized oligomer is shown in Figure 4. 
 
 
Figure 4: Pluronic L-31 functionalized with reactive diacrylate end groups shown in red 
 
3.1.3 Prepolymer Preparation 
Photopolymers on their own will not crosslink in the presence of UV light [18].  They require 
the addition of small amounts of photoinitiator to catalyze the reaction.  The photoinitiator 
absorbs the UV light and creates a reactive intermediary that begins the crosslinking process 
[26].  For the chemistries described in this research, crosslinking occurs via the free-radical 
polymerization process.  Two weight percent of the photoinitiator (2,2-dimethoxy-2-
phenylacetophenone, Sigma Aldrich CAS 24650-42-8) (DMPA) was dissolved in a small 
amount of acetone and added to both the PPGDA and functionalized Pluronic L-31.  
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Photoinitiator concentrations were kept as low as possible while still permitting for the polymer 
to be UV cured as the photoinitiator is known to be cytotoxic. 
 
3.2 Experimental Methods 
 
3.2.1 Determination of the Working Curve 
Before the fabrication of parts, the Working Curve of each polymer was calculated to 
determine the processing parameters of each material [36].  To accomplish this, the prepolymer 
surface was illuminated fully by the DMD with a known exposure (4.9 mW/cm2) and duration to 
create a thin film [18].  These films were then measured with a micrometer to determine their 
cured thickness.  Several films (n=4) were created for four different exposure values.  The film 
thicknesses and their associated exposures were entered into a MatLab program that plots the 
exposure versus the cure depth.  The critical exposure and depth of penetration parameters were 
extracted from the resulting graph.  With these parameters, the exposure required to fabricate a 
film of desired thickness can be calculated. 
 
3.2.2 Film and Benchmark Part Fabrication 
Films of PPGDA and Pluronic L-31 were created to test cell viability on each material.  
Films provide an easy surface on which to seed cells and can be easily fabricated.  The films 
were fabricated by placing 0.25 mL of either PPGDA or Pluronic L-31 with 2 wt% photoinitiator 
into 24 well plates and passed under a high power UV light source for 6 seconds to crosslink the 
prepolymer.  The films were passed under the light source eight times to ensure that the polymer 
was fully crosslinked.  Each well was rinsed with IPA to remove any uncured prepolymer from 
the surface of the film. 
 
A benchmark part was designed to determine the XY minimum feature size, the XY 
accuracy, the Z minimum feature size and the Z accuracy of the machine and polymer.  The part 
was designed to be sliced and fabricated with 25 micron layers.  The cylindrical extrusions on 
the top plane of the part incrementally reduce in diameter from 200 microns to 5 microns along 
both the X and Y axes.  These cylinders are used to measure the minimum feature size 
achievable in the XY plane.  The cross-shaped extrusions on the top plane of the part all have the 
same dimensions and are located equidistant from one another. By measuring the relative 
distances of the cross-features, the accuracy of the XY plane can be determined.  The third 
feature on this part is the cross beam on the four lateral faces. Measuring the thickness of the 
cross beams allows for the determination of the Z-dimension accuracy.  The final set of features 
are the extrusions on the XZ and YZ faces. These extrusions range in Z height thickness from 
200 microns to 25 microns. Measuring the thickness of the smallest structure, the Z accuracy and 
minimum Z axis feature size can be determined.   
 
To construct the test parts shown in the CAD model in Figure 5, the model was first sliced 
into 25 μm layers in NetFabb.  These images were projected onto the material systems at a light 
intensity of 4.9 mW/cm2 for an amount of time to achieve a 25 μm cure depth as determined by 
the working curve.  The remainder of the fabrication was carried out according to the procedure 
described in Section 2.2. After the parts were fabricated, they were left to dry, rinsed with IPA, 




Figure 5: Isometric image of the benchmark characterization part 
 
3.2.3 Mechanical Testing 
Mechanical testing was conducted in order to compare the mechanical properties of the 
polymers being used to those of actual tissues.  Clearly, the polymers must be strong enough to 
provide a supporting structure on which the cells can grow but should not be significantly 
stronger than the tissue that they intend to replace [5].  There will always be some mismatch 
between the stiffness and hardness of tissues and the biomaterials intended to replace them, but 
reducing this disparity is critical to creating viable tissue engineering scaffolds. 
 
Thin films of PPGDA and Pluronic L-31 were cured in teflon petri dishes using a high power 
broadband UV light source to impart 222 mJ/cm2 of exposure.  Each well was rinsed with IPA to 
remove any uncured prepolymer from the surface of the film.  The films were then trimmed into 
rectangles approximately 5mm wide and 20mm long with a razor blade.  The samples were 
tested using an Intron 5500R and Bluehill 2 Instron Software package at a strain rate of 
5mm/min. 
 
3.3 Cell Culture 
A cell study was conducted to determine the biocompatibility of the PPGDA and Pluronic L-
31.  Materials used in tissue engineering scaffolds cannot be cytotoxic or cells will be unable to 
grow on them.  In particular, the photoinitiator DMPA is known to be toxic.  To reduce the 
toxicity of the cured materials, the amount of DMPA added to the prepolymer was kept as low as 
possible while still allowing for polymerization to occur (2 wt% DMPA).  MC3T3-E1 mouse 
preosteoblasts were seeded onto films fabricated in the bottom of polystyrene cell culture plates.  
Cell viability was quantified using an MTS assay after culturing the cells for 1, 4, and 7 days. 
 
3.3.1 Cell Seeding and Cytotoxicity 
Films were sterilized by spraying them with 70% ethanol and exposing them to UV light for 
1 hour.  The UV light intensity used to sterilize the films was significantly less than that of the 
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Microstereolithography system so it was not expected to have any impact on the polymer’s 
mechanical properties.  Cell media was placed on PPGDA and Pluronic L-31 films for 30 
minutes in preparation for cell seeding.  Half of the films also received fibronectin (1mg/mL of 
media) to promote cell adhesion to the films.  MC3T3-E1 mouse preosteoblasts were trypsinized, 
counted, and resuspended in fresh media.  The cells were seeded at a density of 104 cells/cm2 of 
surface area of the film.  This corresponded to 19,000 cells being placed on each film.  The same 
quantity of cell suspension was also added to tissue culture treated polystyrene well plates as a 
control.  The cells were given one hour to attach to the films and then the media was removed.  
The wells were then filled with fresh media containing 10% fetal bovine serum (FBS) and 1% 
Penicillin Streptomyacin. 
 
3.3.2 Cell Viability 
Cell survival and proliferation for films and tubes was measured on days 1, 4, and 7 after 
seeding.  Cells grown for 1 and 4 days did not receive fresh media while those grown for 7 days 
received fresh media on the fourth day.   An MTS assay, was used to quantify the number of 
cells on the films and tubes.  To create a control curve, 100, 1,000, 10,000, 100,000, 500,000 
cells were suspended in 100 μl of media in wells.  20 μl of the MTS assay was added to each and 
allowed to incubate for four hours at 37°C.  The 120 μl was then transferred into a 96 well plate 
and the absorbance was measured at 490 nm.  To quantify the number of cells on the films and 
scaffolds, the media was removed from the respective wells and 100 μl of fresh media was 
added.  20 μl of the MTS assay was added and the cells were incubated for 4 hours at 37°C.  The 
media and MTS assay were transferred to a 96 well plate and their absorbance was measured.  
The number of cells on each scaffold and film was determined by comparing the measured 
absorbance to a fit of the control curve. 
 
 
4. Results and Discussion 
 
4.1 Determination of Working Curve 
The critical exposure of the PPGDA with 2 wt% photoinitiator was found to be 6.05 mJ/cm2 
and the depth of penetration was 398 μm.  Characterization of the Pluronic L-31 with 2 wt% 
photoinitiator found the critical exposure to be 17.2 mJ/cm2 and the depth of penetration to be 
289 μm.  These parameters were used when fabricating the benchmark parts. 
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Figure 6: Working Curves for PPGDA and Pluronic L-31 both with 2 wt% photoinitiator 
 
 
4.2 Machine Capabilities 
The benchmark part described in Section 3.2.2 was fabricated three times and its features 
were measured to determine accuracy and minimum achievable feature size.  The results 
obtained were dependent not only on the accuracy and precision of the system, but also on the 
material in use. This difference could be attributed to the differences in nanostructure between 
the Pluronic L-31 and the PPGDA.  The coblock structure of the Pluronic L-31 might allow it to 
collapse on itself.  Further investigation will be necessary to understand why different polymers 
yield minimum feature sizes that are so different.  The XY axis minimum feature size was 
determined by measuring the diameter of the smallest cylinder that was successfully fabricated in 
this plane.  The smallest fabricated cylinder of the PPGDA sample averaged 212 μm in diameter 







Figure 7: X axis measurements for minimum feature size analysis on a benchmark part fabricated 
with PPGDA 
 
Sixteen key measurements were made on each sample to determine the dimensional accuracy 
of the system in the XY plane.  The average error in the XY plane was found to be 2.5% for 
PPGDA and 6% for Pluronic L-31. 
 
Table 1: Summary of Machine Capabilities using both PPGDA and Pluronic L-31 
 PPGDA Pluronic L-31 
Minimum Feature Size in XY Plane 212 μm 57 μm 
Error in XY Plane 2.5% 6% 
Error in Z Axis 119% 83% 
 
The Z accuracy of the system with both the PPGDA and Pluronic L-31 was extremely poor 
due to a print-through effect.  In fact, the only meaningful quantitative value that could be 
determined was the thickness of the cross beam. As the cross beam in most parts generated an 
arc-like shape, the measurement was made at the center of the beam for consistency.   These 
measurements showed a 119% error in observed thickness when compared to designed thickness 
for the PPGDA and an 83% error for the Pluronic L-31. The lack of lateral definition was 
somewhat expected due to the high depths of penetration (Dp) of the PPGDA and Pluronic L-31 
with 2wt% initiator. 
 
Despite the error observed in the Z axis accuracy, some parts were fabricated that showed good 
resemblance when compared to their intended designs.  The 4mm x 4mm x 8mm scaffold shown 
in Figure 8 (left) was designed to resemble a possible tissue engineering scaffold.  A Micro 
Computed Tomography (Micro CT) scan of the fabricated scaffolds are shown in Figure 8.  
Arching can be seen below the horizontal crossbeams suggesting error in Z dimensional 
accuracy, however the parts maintain similarity to the design. 
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Figure 8: CAD model of designed scaffold (left). Micro-CT scan model of the fabricated 
PPGDA scaffold (middle) and Pluronic L-31 (right) 
 
The vertical build rate is highly dependent on the prepolymer properties such as critical 
exposure and viscosity. With higher critical exposure, a prepolymer takes longer to reach the gel 
point, and extends the time per layer. Similarly, the viscosity of the prepolymer contributes to the 
refresh duration required after the dipping recoat process. Higher viscosity prepolymers take 
longer to settle, extending the time per layer, and thus the vertical build rate.  The vertical build 
rates for PPGDA and Pluronic L-31 with parts sliced in 25 μm layers were found to be 
approximately 360 layers per hour and 325 layers per hour respectively.  A 5mm tall part with 25 
μm layers made of PPGDA would take approximately half an hour to complete. 
 
4.3 Mechanical Testing 
The mechanical strengths of both the PPGDA and Pluronic L-31 were found to be 
physiologically relevant.  The Young’s Modulus and largest observed strengths of both materials 
were slightly higher than that of aortic tissue, while still significantly less than that of skin.  The 
largest strains observed in both materials were somewhat inferior to those of the human tissues.  
While both polymers had Young’s Moduli that were similar to those of human tissue, the 
PPGDA was significantly stiffer than the Pluronic L-31.  The PEG endgroups of the Pluronic L-
31 may have adversely impacted its stiffness while imparting additional ductility.  Additionally, 
it is possible that the block copolymer structure of the Pluronic L-31 may have allowed the 









Table 2: Summary of the mechanical testing results of PPGDA, Pluronic L-31 and literature 
values for skin and aorta 
 PPGDA Pluronic L-31 Skin[37, 38] Aorta[39] 
Young’s Modulus  
(MPa) 
 




1.04  ± 0.30 0.74  ± 0.12 1-20 0.3-0.8 
Ultimate Tensile  
Strain (%) 
13.14 ± 3.77 26.9  ± 2.66 30-70 50-100 
 
4.4 Cell Viability 
The cell viability assay conducted show that both the PPGDA and Pluronic L-31 are not 
cytotoxic.  Although extensive cellular growth did not occur after 7 days, the continued presence 
of the cells on the material is meaningful enough to warrant additional investigation into these 
materials.  In addition, the PPGDA and the PPG blocks of the Pluronic L-31 are highly 
hydrophobic and thus significantly fewer cells should be expected on these materials when 
compared to the hydrophilic polystyrene.  Furthermore, these results are consistent with the 
hydrophillic PEG endgroups of the Pluronic L-31 that make it somewhat more biocompatible 
than the PPGDA. 
 
 




















5. Conclusions and Future Work 
This research has demonstrated the processability of the novel photopolymers PPGDA and 
Pluronic L-31 via MPμSL to fabricate parts with features on the micron scale.  These materials 
were found to have mechanical properties similar to those of human tissue and a seven day cell 
assay found that the polymers were not cytotoxic.  In addition, it was shown that the PEG 
endgroups on the Pluronic L-31 had a discernable effect on not only the mechanical and 
biocompatibility properties of the material but also on the minimum feature size that could be 
achieved. 
These results warrant further investigation into the application of these materials into tissue 
engineering scaffolds.  Future work will focus on seeding cells onto three dimensional scaffolds 
and observing their growth, migration, and differentiation. In addition, the effect of the Pluronic 
L-31’s block copolymer structure on both the nanoscale and microscale structure of objects 
processed by MPμSL will be investigated.  Finally, chemical cues (e.g. growth hormones, 
collagen) will be incorporated into the tissue engineering scaffolds to improve biocompatibility 
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